European medtech startups were among the 74 companies receiving a combined €382 million in grants and investments, the 2022 European Innovation Council Accelerator said this week.
Each company will be eligible for up to €17.5 million (about $18.8 million in U.S. currency) worth of grants and equity investments. Most of the funding will be available in the next two or three months, with equity investments expecting to be finalized this fall.
The startups include Estonia-based Seventh Sense, which uses telehaptics to help blind and visually impaired people navigate their surroundings, and Finland-based Tilt Biotherapeutics, the developer of a novel oncolytic immunotherapy for ovarian, head and neck, and lung cancers.
Get the full story at our sister site, Medical Design & Outsourcing.